Oswald S	FIS_1134
Characterization of the Intestinal and Hepatic Uptake/Efflux Transport of the Magnetic Resonance Imaging Contrast Agent Gadolinium-Ethoxylbenzyl-Diethylenetriamine-Pentaacetic Acid.
Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
Differential Expression of the resistance 1 (MDR1) Protein in prostate cancer cells is Independent from anticancer drug Treatment and Y box binding Protein 1 (YB-1) aktiv
Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics.
Quantitative LC-MS/MS determination of flupirtine, its N-acetylated and two mercapturic acid derivatives in man.
LC-MS/MS method for the determination of clodronate in human plasma.
Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine.
Targeted adsorption of molecules in the colon with the novel adsorbent-based Medicinal Product, DAV132: A proof of concept study in healthy subjects.
Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy.
Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of the whole-gut transit time in healthy subjects.
Defining Human Pathways of Drug Metabolism In Vivo through the Development of a Multiple Humanized Mouse Model.
Pharmacokinetics and pulmonary distribution of clarithromycin and rifampicin after concomitant and consecutive administration in foals.
Simultaneous magnetic resonance imaging and pharmacokinetic analysis of intramuscular depots.
Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade.
Expression, regulation and function of intestinal drug transporters: an update.
Expression, regulation and function of intestinal drug transporters: an update.
Rapid LC-MS/MS method for the determination of 4-hydroxycholesterol/cholesterol ratio in serum as endogenous biomarker for CYP3A activity in human and foals.
Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue.
Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue.
Expression of Organic Anion Transporting Polypeptide 1A2 in Red Blood Cells and Its Potential Impact on Antimalarial Therapy.
Effects of frequently used pharmaceutical excipients on the organic cation transporters 1-3 and peptide transporters 1/2 stably expressed in MDCKII cells.
Expression and Regulation of Drug Transporters and Metabolizing Enzymes in the Human Gastrointestinal Tract.
Pharmacological indices and pulmonary distribution of rifampicin after repeated oral administration in healthy foals.
Pharmacological indices and pulmonary distribution of rifampicin after repeated oral administration in healthy foals.
Reference intervals for Serum Sphingosine-1-Phosphate in the Population-based Study of Health in Pomerania
Reference intervals for Serum Sphingosine-1-Phosphate in the Population-based Study of Health in Pomerania
Data on subgroup specific baseline characteristics and serum sphingosine-1-phosphate concentrations in the Study of Health in Pomerania.
Data on subgroup specific baseline characteristics and serum sphingosine-1-phosphate concentrations in the Study of Health in Pomerania.
The organic anion transporting peptide (OATP) 2B1 is localized in the basolateral membrane of the human jejunum and Caco-2 monolayers.
The organic anion transporting peptide (OATP) 2B1 is localized in the basolateral membrane of the human jejunum and Caco-2 monolayers.
The Ussing Chamber Assay to Study Drug Metabolism and Transport in the Human Intestine.
The Ussing Chamber Assay to Study Drug Metabolism and Transport in the Human Intestine.
Clinically Relevant Multidrug Transporters Are Regulated by microRNAs along the Human Intestine.
A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.
A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.
Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS/MS in human serum, urine and fecal samples.
Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS/MS in human serum, urine and fecal samples.
Pretransplant 4?-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation.
Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes.
Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes.
Release of Platelet-Derived Sphingosine-1-Phosphate Involves Multidrug Resistance Protein 4 (MRP4/ABCC4) and Is Inhibited by Statins
Release of Platelet-Derived Sphingosine-1-Phosphate Involves Multidrug Resistance Protein 4 (MRP4/ABCC4) and Is Inhibited by Statins
Affinity of Ketamine to Clinically Relevant Transporters.
Affinity of Ketamine to Clinically Relevant Transporters.
LC-MS/MS method for the simultaneous quantification of intestinal CYP and UGT activity.
LC-MS/MS method for the simultaneous quantification of intestinal CYP and UGT activity.
Low dose caffeine as a salivary tracer for the determination of gastric water emptying in fed and fasted state: A MRI validation study
Dysregulation of mucosal membrane transporters and drug metabolizing enzymes in ulcerative colitis.
Organic Anion Transporting Polypeptide (OATP) transporter expression, localization and function in the human intestine
Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis
CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box
Gas Plasma-Conditioned Ringer's Lactate Enhances the Cytotoxic Activity of Cisplatin and Gemcitabine in Pancreatic Cancer In Vitro and In Ovo.
Protein abundance of hepatic drug transporters in patients with different forms of liver damage.
Heterogeneous antimicrobial activity in broncho-alveolar aspirates from mechanically ventilated Intensive Care Unit patients
Protein abundance of clinically relevant drug transporters in the human kidney
Membrane transporters in human parotid gland - targeted proteomics approach
Transcriptional and posttranslational regulation of duodenal P-glycoprotein and MRP2 in healthy human subjects after chronic treatment with rifampicin and carbamazepine
The reference liver Â– ABC and SLC drug transporters in healthy donor and metastatic livers
Protein abundance of clinically relevant drug transporters in the human liver and intestine: a comparative analysis in paired tissue specimens
Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism
Protein abundance of clinically relevant drug metabolizing enzymes in the human liver and intestine: A comparative analysis in paired tissue specimens.
OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists
Intestinal drug transporters in pathological states: an overview
The orphan solute carrier SLC10A7 is a novel negative regulator of intracellular calcium signaling
Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where is the Evidence for its Relevance in Drug-Drug Interactions?
Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations.
Comparative Hepatic and Intestinal Efflux Transport of Statins
Targeting OCT3 attenuates doxorubicin-induced cardiac injury
Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue